Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

NVS
Novartis AG - ADR
stock NYSE ADR

Market Open
5/30/2023 1:07:30 PM EDT
96.36USD-1.533%(-1.50)2,410
96.80Bid   96.84Ask   0.04Spread IEX
Pre-market
5/30/2023 9:29:30 AM EDT
96.90USD-0.981%(-0.96)0
After-hours
5/26/2023 4:00:30 PM EDT
97.86USD0.000%(0.00)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
219.458B
Headquarters
Basel, Basel Stadt, Switzerland
Industry
Drug Manufacturers-General
Next Earnings
2023-07-18 (49d)
Last Dividend
2023-03-092.255
Last Split
2019-04-091.11607143for1
Related
GSKABTBMYJNJPFESNYMRKTEVAXLV
NVS Stats
Avg. Vol. 10 Day
1,862,049
Avg. Vol. 30 Day
1,679,361
Dividend Yield
3.498%
Dividend Rate (ttm)
3.499
Employees
103,000
Market Cap
219,457,756,183
Shares Out.
2,277,477,752
P/E Ratio
32.42
EPS (ttm)
3.240
On/Off Exchange
68%/32%
6 Month Beta
0.16
1 Year Beta
0.40
2 Year Beta
0.37
3 Year Beta
0.41
52 Week Low
71.00
52 Week High
105.56
SMA50
101.00
SMA200
88.93
1 Week
-3.88%
1 Month
-6.03%
3 Month
+13.21%
6 Month
+7.59%
1 Year
+5.96%
2 Year
+9.35%
5 Year
+27.24%
Jan 31, 2022
04:51PM EST  Amgen Reports In 8K Filing Co Entered Into Amendment No. 3 To Exclusive License & Collaboration Agreement With Novartis   Benzinga
Jan 26, 2022
08:00AM EST  Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announces the appointment of Cintia Piccina as Chief Commercial Officer effective January 31, 2022.   GlobeNewswire Inc
Jan 18, 2022
04:25AM EST  Molecular Partners Finalized License Agreement with Novartis for Ensovibep for COVID-19; Molecular Partners to Receive Milestone Payment of CHF150M, 22% Royalty on Ensovibep Sales in Relevant Territories   Benzinga
01:26AM EST  Molecular Partners AG (MOLN), a clinical-stage biotech company developing DARPin therapeutics, Tuesday said it has entered into a license agreement with Novartis AG (NVS), under which the Swiss drug major will in-license global rights to ensovibep from Molecular Partners.   RTTNews
01:12AM EST  Molecular Partners Finalizes License Deal With Novartis For Ensovibep For COVID-19   RTTNews
More News
Profile
Novartis AG is a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and Cambridge, Massachusetts, United States. It is one of the largest pharmaceutical companies in the world.

NVS Stock Summary

Novartis AG - ADR (NYSE:NVS) stock price today is $96.36, and today's volume is 2,410. NVS is down -1.533% today. The 30 day average volume is 1,679,361. NVS market cap is 219.458B with 2,277,477,752 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC